- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Dihydrouracil Dehydrogenase (NADP)
Total 1139 results
-
University of ArizonaActive, not recruiting
-
Kristina LindemannUniversity Hospital of North Norway; Haukeland University Hospital; Sorlandet... and other collaboratorsCompletedOvarian Cancer | Peritoneal CancerNorway
-
Royal Marsden NHS Foundation TrustAstraZenecaUnknownGastric Cancer | Oesophageal Cancer | Gastro-Oesophageal Junction CancerUnited Kingdom
-
Tesaro, Inc.Approved for marketingRecurrent Ovarian Cancer
-
Vejle HospitalAbbottCompletedRecurrent, Epithelial Ovarian CancerDenmark
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityAstraZenecaRecruitingProstate Cancer | Prostate Carcinoma | Metastatic Castration-resistant Prostate CancerChina
-
TakedaRecruiting
-
California Pacific Medical Center Research InstituteTesaro, Inc.; Vanderbilt-Ingram Cancer Center; Huntsman Cancer InstituteRecruitingMetastatic MelanomaUnited States
-
University Medical Center GroningenAbbVie; Dutch Cancer SocietyWithdrawn
-
TakedaCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerJapan
-
PfizerIn Expanded Access, treating physicians are the SponsorsAvailableMetastatic Castration-Resistant Prostate Cancer
-
Asan Medical CenterNational Cancer Center, Korea; Samsung Medical Center; Seoul St. Mary's Hospital and other collaboratorsCompletedEpithelial Ovarian CancerKorea, Republic of
-
Zhongda HospitalCompleted
-
AstraZenecaCompletedHER2-ve Metastatic Breast Cancer | Germline BRCA1/2 Mutations | Somatic BRCA1/2 MutationsItaly, Spain, Poland, Taiwan, Canada, France, Germany, Korea, Republic of, Hungary, Japan, Russian Federation, Turkey, United Kingdom, United States, Bulgaria
-
Grupo Español de Investigación en Cáncer de OvarioAstraZeneca; Apices Soluciones S.L.Completed
-
Grupo Español de Investigación en Cáncer de OvarioClovis Oncology, Inc.CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerSpain
-
Tesaro, Inc.Myriad Genetics, Inc.; Facing Our Risk of Cancer EmpoweredCompletedOvarian Neoplasms | Ovarian CancerUnited States, Canada
-
Samsung Medical CenterCompleted
-
Korea University Anam HospitalTakeda; Korean Cancer Study GroupNot yet recruiting
-
The University of Hong KongRecruitingEndometrial CancerHong Kong
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMetastatic Breast Cancer in Germline-PALB2 Mutations Carriers
-
National University Hospital, SingaporeRecruitingAdvanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast CancersSingapore
-
Tianjin Huanhu HospitalRecruiting
-
Royal Marsden NHS Foundation TrustRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited Kingdom
-
Institute of Cancer Research, United KingdomAstraZeneca; Cancer Research UKRecruitingGynaecological CancersUnited Kingdom
-
University of UtahClovis Oncology, Inc.Terminated
-
Mario Negri Institute for Pharmacological ResearchNorth Eastern German Society of Gynaecological OncologyActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaItaly, Germany
-
Dana-Farber Cancer InstituteTesaro, Inc.Active, not recruiting
-
Matthew GalskyIcahn School of Medicine at Mount Sinai; AstraZenecaCompletedMetastatic Urothelial CancerUnited States
-
AstraZenecaCompletedBRCA or HRR+ Mutated Ovarian Cancer PatientsItaly, Spain, Canada, Czechia, Poland, United Kingdom, Hungary, Bulgaria
-
PfizerTerminated
-
UNICANCERClovis Oncology, Inc.; Fondation ARCCompletedMetastatic Breast CancerFrance
-
AstraZenecaNo longer availablePSR Ovarian Cancer With a BRCA MutationJapan
-
Trius Therapeutics LLCCompleted
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownNon Small Cell Lung CancerFrance
-
Daping Hospital and the Research Institute of Surgery...UnknownCervical Cancer | ComplicationsChina
-
Dana-Farber Cancer InstituteWithdrawnOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
GlaxoSmithKlineRecruiting
-
OnxeoRecruitingBreast Cancer | Metastatic Castration-resistant Prostate Cancer | Recurrent Epithelial Ovarian CancerUnited States
-
Yongpeng WangRecruiting
-
Centre Leon BerardGlaxoSmithKlineRecruitingMetastatic Pancreatic CancerFrance
-
Haider MahdiPfizer; Zenith EpigeneticsRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
University of ChicagoAstraZenecaRecruitingMesothelioma | Homologous Recombination DeficiencyUnited States
-
Northwell HealthTesaro, Inc.RecruitingEndometrial Cancer | Endometrial Carcinoma | Uterine Serous Carcinoma | Cancer of the Endometrium | Papillary Serous Endometrial CarcinomaUnited States
-
Massachusetts General HospitalPfizerRecruiting
-
AstraZenecaActive, not recruitingSolid TumorsBelgium, United Kingdom, Switzerland, Australia
-
North Eastern German Society of Gynaecological...Clovis Oncology, Inc.; Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus...Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | Clear Cell CarcinomaGermany
-
Shadia Jalal, MDGlaxoSmithKline; Indiana University School of MedicineActive, not recruitingAdenocarcinoma | Gastric Cancer | Esophageal CancerUnited States
-
PfizerCompletedBreast Neoplasms | Metastatic Breast CancerUnited States
-
PfizerActive, not recruitingNeoplasms | Breast NeoplasmsJapan